Russell Frank Company’s Insys Therapeutics, Inc. INSY Stock Holding History

Russell Frank Company’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.92M	Sell	120,278 -155,177	-56%	-$2.95M	﹤0.01%	1876
2015 Q4	$8.09M	Buy	275,455 +100,563	+58%	+$2.79M	0.01%	1001
2015 Q3	$4.98M	Buy	174,892 +40,626	+30%	+$1.5M	0.01%	1273
2015 Q2	$4.82M	Buy	134,266 +1,218	+0.9%	+$37.9K	0.01%	1447
2015 Q1	$3.87M	Buy	+133,048	New	+$3.52M	0.01%	1394
2013 Q4	–	Sell	-167,484	Closed	-$1.85M	–	3208
2013 Q3	$1.85M	Buy	+167,484	New	+$1.38M	﹤0.01%	1906

Other funds holding INSY

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Russell Frank Company's INSY Position: Q1 2016 in Review

Russell Frank Company reduced its Insys Therapeutics, Inc. (INSY) stake by 56% in Q1 2016, selling an estimated $2.95M and leaving 120,278 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1876.

Russell Frank Company first reported a position in INSY in Q3 2013 and has held it in 6 quarters since. The position peaked at $8.09M in Q4 2015. 138 funds tracked by Wall St. Rank hold INSY as of Q1 2016.

Russell Frank Company held 120,278 shares of Insys Therapeutics, Inc. worth $1.92M as of Q1 2016.
Russell Frank Company sold 155,177 Insys Therapeutics, Inc. shares in Q1 2016, an estimated $2.95M.
Insys Therapeutics, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1876 holding.
Russell Frank Company first reported a position in Insys Therapeutics, Inc. in Q3 2013 and has held it in 6 quarters since.
Russell Frank Company's Insys Therapeutics, Inc. position peaked at $8.09M in Q4 2015.
138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.